Introduction HPV Prevention & Control Board Meeting Antwerp, Belgium - Alex Vorsters
Immunogenicity and tolerability of HPV vaccine in women aged 15-55 years; study findings and way forward - Tino F. Schwarz
Potential Benefits of HPV Vaccine in sexually active women: delivering the promise - John Schiller
Immune cross talk of HPV Specific Antibody Response; Cross Reactivity, Neutralizing Activity, Mucosal Secretion and Infection Prevention - Fiona RM van der Klis
Vaccine-induced HPV-specific antibodies in cervicovaginal secretions - Jade Pattyn
Immunising older cohorts : pros and cons - Margaret Stanley & Xavier Bosch
Pap smear collection: an increased risk of HPV infection? An objective study in rhesus macaques' model - John Schiller
HPV vaccination in relation to conization: A Danish nationwide study - Susanne Krüger Kjær
Transmission Reduction and Prevention with HPV Vaccination (TRAP-HPV) study - Aaron MacCosham and Eduardo Franco
Overview of Health Economics Models for HPV Vaccination of Mid-Adults - Harrell Chesson
Directionality of HPV Infection transmission in heterosexual couples; a systematic review and meta-analysis - Aaron MacCosham and Eduardo Franco
HPV Vaccination for sex workers: finding a balance between pros and cons - Maarten Schim van der Loeff
Baseline HPV Prevalence in rectal swabs from men attending a sexual health clinic in Scotland: assessing the potential impact of a selective HPV Vaccination programme for men who have sex with men - Ross Cameron
Towards cervical cancer elimination: the context of HPV Vaccination - Paul Bloem
